Design Therapeutics, Inc. (DSGN) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$79.47M | -27.4% |
| 2024 | -$62.38M | +20.2% |
| 2023 | -$78.19M | -15.7% |
| 2022 | -$67.59M | -88.6% |
| 2021 | -$35.83M | -330.1% |
| 2020 | -$8.33M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$79.47M | -27.4% |
| 2024 | -$62.38M | +20.2% |
| 2023 | -$78.19M | -15.7% |
| 2022 | -$67.59M | -88.6% |
| 2021 | -$35.83M | -330.1% |
| 2020 | -$8.33M | — |